policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Therapeutic pet food health claims
The FDA uses enforcement discretion in overseeing certain pet food claims. While many of these could legally be considered drugs, certain claims are…
AVMA news
FDA warns that topical drug for humans can be deadly to pets
As of September, the Food and Drug Administration had received 14 reports involving 20 dogs that had been accidentally exposed to topical…
AVMA news
Vaccine hesitancy gives some US dog, cat owners cold feet
The connection between attitudes toward human and pet vaccines and how those of some people are changing is forcing veterinary professionals to more…
AVMA news
More options expected for treating rare conditions in dogs and cats
The Food and Drug Administration’s Center for Veterinary Medicine announced plans to increase the maximum numbers of dogs and cats that can be…
AVMA news
Gene therapy may soon help treat mitral valve disease
Phibro Animal Health and Rejuvenate Bio are developing an expected gene therapy for canine mitral valve disease.
AVMA news
Silicone tags used to identify dogs’ pollution exposures
Silicone tags attached to dogs’ collars could someday help veterinarians measure environmental pollution exposures, which could help them assess…
AVMA news
Drug approved to treat dogs for chemotherapy-related diarrhea
Food and Drug Administration officials granted conditional approval in mid-December for the oral prescription drug Canalevia-CA1, the first drug with…
AVMA news
Canine parvovirus treatment receives conditional approval
The U.S. Department of Agriculture has granted a conditional license for the Canine Parvovirus Monoclonal Antibody—Elanco's first monoclonal antibody…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
AVMA releases resources on antimicrobial resistance susceptibility testing
The AVMA’s Committee on Antimicrobials (CoA) recently created one-pagers on antimicrobial susceptibility testing (AST) to help veterinarians make…
AVMA news
Raw pet food diets, pet population management policies headed to HOD
The AVMA House of Delegates, during its regular winter session, being held January 5-6, 2024, in Chicago, will vote on six resolutions that would…
AVMA news
VMX 2023 draws a crowd for 40th anniversary
Several new studies were unveiled at @the_NAVC Veterinary Meeting & Expo this January in Orlando, Florida, including research identifying 30 different…
policy
Joint AVMA-FVE-CVMA statement on the benefits of animal vaccination programs in advancing animal and human health
This statement has been adopted jointly by the AVMA, Federation of Veterinarians of Europe and Canadian Veterinary Medical Association.
policy
Model bill and regulations to assure appropriate care for dogs intended for use as pets
This resource can serve as a guide for legislators and other government officials involved in developing legislation and regulations to assure…